A Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Investigational Intravenous Peramivir in Children With Influenza Disease (CASG 117).
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 20 Oct 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 14 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Jul 2011 Actual initiation date Jan 2011 added as reported by ClinicalTrials.gov.